Date published: 2025-9-17

1-800-457-3801

SCBT Portrait Logo
Seach Input

TMEM16J Inhibitors

The chemical class TMEM16J Inhibitors encompasses a range of compounds with diverse chemical structures and properties that are capable of indirectly modulating the activity of the TMEM16J protein. These compounds interact with various cellular mechanisms and can influence the function of TMEM16J through alterations in ion transport, membrane potential, and phospholipid scrambling. The action of these compounds is rooted in their ability to modify the biophysical properties of the cellular membrane or to influence the ion gradients and signaling pathways that TMEM16J is associated with. Tannic Acid, Progesterone, and Ibuprofen have the capacity to change the lipid bilayer's character, which may affect TMEM16J's membrane integration or its structural conformation. This alteration can lead to modified protein function by impacting the protein's accessibility to its substrates or its interaction with other cellular components.

Other compounds, such as Niflumic Acid, Flufenamic Acid, and Bumetanide, target ion transport mechanisms. By inhibiting specific ion channels or transporters, these compounds can disrupt the ionic balances across the cell membrane, thereby influencing TMEM16J activity if it is coupled to the ion fluxes these molecules regulate. Ionomycin and Verapamil, which modulate intracellular calcium levels, can also affect TMEM16J activity given its potential regulation by calcium. DIDS and Ethacrynic Acid, by altering anion fluxes and cellular redox states, respectively, present another layer of indirect modulation of TMEM16J function, potentially impacting the protein's ability to mediate phospholipid scrambling or ion transport. Monensin, by altering intracellular pH and sodium levels, and Genistein, by targeting tyrosine kinase signaling pathways, can lead to downstream effects that modulate the cellular context in which TMEM16J operates. These effects can result in changes to TMEM16J's activity by altering the regulatory environment or the protein's post-translational modifications.

SEE ALSO...

Items 291 to 11 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING